Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference9 articles.
1. Michallet M, Dreger P, Sobh M et al (2020) Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia. Bone Marrow Transplant 55:884–890. https://doi.org/10.1038/s41409-019-0742-7
2. Innocenti I, Sora F, Autore F, Chiusolo P, Giammarco S, Metafuni E, Bacigalupo A, Sica S, Laurenti L (2021) Efficacy of ibrutinib in late relapse chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation. Hematol Oncol 39:267–269. https://doi.org/10.1002/hon.2826
3. Tam CS, Kimber T, Seymour JF (2017) Ibrutinib monotherapy as effective treatment of central nervous system involvement by chronic lymphocytic leukaemia. Br J Haematol 176:829–831. https://doi.org/10.1111/bjh.14000
4. Kantarjian H, Thomas D, O’Brien S, Cortes J, Giles F, Jeha S, Bueso-Ramos CE, Pierce S, Shan J, Koller C, Beran M, Keating M, Freireich EJ (2004) Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer 101:2788–2801. https://doi.org/10.1002/cncr.20668
5. Larson RA, Dodge RK, Linker CA, Stone RM, Powell BL, Lee EJ, Schulman P, Davey FR, Frankel SR, Bloomfield CD, George SL, Schiffer CA (1998) A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111. Blood 92:1556–1564
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献